# Treatment Strategies in IgG4-RD Patients With Re-elevation of Serum IgG4 Level During Maintenance Remission Period

> **NCT05974683** · NA · UNKNOWN · sponsor: **Peking Union Medical College Hospital** · enrollment: 108 (estimated)

## Conditions studied

- Autoimmune Diseases

## Interventions

- **DRUG:** placebo
- **DRUG:** mycophenolate mofetil

## Key facts

- **NCT ID:** NCT05974683
- **Lead sponsor:** Peking Union Medical College Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-08-01
- **Primary completion:** 2025-12
- **Final completion:** 2025-12
- **Target enrollment:** 108 (ESTIMATED)
- **Last updated:** 2023-08-03

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05974683

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05974683, "Treatment Strategies in IgG4-RD Patients With Re-elevation of Serum IgG4 Level During Maintenance Remission Period". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT05974683. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*